Topiroxostat-d4 is the tetra-deuterated form of Topiroxostat (FYX-051), which is a potent and orally bioactive xanthine oxidoreductase (XOR) inhibitor with the potential to be used for hyperuricemia treatment. It inhibits XO with an IC50 value of 5.3 nM and a Ki value of 5.7 nM.

纯度：≥98%

CAS：2732868-49-2